Novo Nordisk AS (NONOF)
105.00
+2.16
(+2.10%)
USD |
OTCM |
Nov 22, 16:00
Novo Nordisk Market Cap: 466.54B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 466.54B |
| November 21, 2024 | 456.95B |
| November 20, 2024 | 468.73B |
| November 19, 2024 | 449.69B |
| November 18, 2024 | 449.68B |
| November 15, 2024 | 454.11B |
| November 14, 2024 | 470.07B |
| November 13, 2024 | 465.75B |
| November 12, 2024 | 468.48B |
| November 11, 2024 | 479.05B |
| November 08, 2024 | 491.91B |
| November 07, 2024 | 471.72B |
| November 06, 2024 | 492.15B |
| November 05, 2024 | 472.60B |
| November 04, 2024 | 488.59B |
| November 01, 2024 | 496.36B |
| October 31, 2024 | 485.06B |
| October 30, 2024 | 493.07B |
| October 29, 2024 | 492.86B |
| October 28, 2024 | 503.50B |
| October 25, 2024 | 512.65B |
| October 24, 2024 | 516.26B |
| October 23, 2024 | 508.32B |
| October 22, 2024 | 520.71B |
| October 21, 2024 | 530.17B |
| Date | Value |
|---|---|
| October 18, 2024 | 522.92B |
| October 17, 2024 | 514.93B |
| October 16, 2024 | 517.42B |
| October 15, 2024 | 543.86B |
| October 14, 2024 | 532.06B |
| October 11, 2024 | 539.94B |
| October 10, 2024 | 524.08B |
| October 09, 2024 | 514.06B |
| October 08, 2024 | 515.18B |
| October 07, 2024 | 525.20B |
| October 04, 2024 | 507.57B |
| October 03, 2024 | 507.56B |
| October 02, 2024 | 523.08B |
| October 01, 2024 | 526.38B |
| September 30, 2024 | 518.99B |
| September 27, 2024 | 528.73B |
| September 26, 2024 | 569.71B |
| September 25, 2024 | 556.40B |
| September 24, 2024 | 569.75B |
| September 23, 2024 | 554.18B |
| September 20, 2024 | 561.50B |
| September 19, 2024 | 592.67B |
| September 18, 2024 | 593.87B |
| September 17, 2024 | 586.43B |
| September 16, 2024 | 614.27B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
114.23B
Minimum
Mar 23 2020
663.39B
Maximum
Jun 25 2024
299.43B
Average
245.41B
Median
Market Cap Benchmarks
| Eli Lilly and Co | 710.10B |
| Genmab AS | 13.12B |
| Ascendis Pharma AS | 7.757B |
| Galecto Inc | 7.402M |
Market Cap Related Metrics
| PE Ratio | 34.02 |
| PS Ratio | 11.92 |
| PEG Ratio | 1.210 |
| Price to Book Value | 25.84 |
| Price to Free Cash Flow | 47.73 |
| Price | 105.00 |
| Earnings Yield | 2.94% |
| PEGY Ratio | 1.153 |
| Operating PE Ratio | 27.23 |
| Normalized PE Ratio | 34.02 |